Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Hold/Sell

Previous Rating

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$65.45
Market Cap
2.78B
Sector
Health Care
Div. Growth
-
P/E
216.0
P/B
4.78
P/S
16.99
Dividend %
-
P/CF
97.5
P/FCF
93.2
Op. Cash Flow
42.4K
FCF
0.7
Op. Margin
12.50%
Net Margin
13.60%
ROE
3.90%
ROI
3.70%
ROA
3.10%
EPS Growth
-11.60%
Current Ratio
9.6
Debt/Equity
16.80%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Navidea Biopharmaceuticals Inc (NAVB) $0.20 - - 40.1M Strong Buy
Quorum Health Corp (QHC) $4.03 - - 140.9M Strong Buy
Integer Holdings Corp (ITGR) $85.72 - - 2.7B Strong Buy
InfuSystem Holdings Inc (INFU) $3.35 - - 61.1M Strong Buy
Correvio Pharma Corp (CORV) $3.14 - - 122.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More